PCSS Office-Based Treatment for Opioid Use Disorders Webinar - Monday, 12/27/2021

Includes a Live Event on 12/27/2021 at 8:00 PM (EST)

This is PART 1 of the 8-hour waiver eligibility training.
NOTE: This training has a starting time of 5:00 pm Pacific Time Zone. Please check your time zone for start time. Please download the Zoom app prior to training. https://zoom.us/ent?zcid=2582

Physicians are required to apply to the Drug Enforcement Agency for a waiver to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder. Those physicians who want to treat more than 30 patients at any one time, must take the 8-hour waiver course.

To treat more than 30 patients, Advanced Practice Registered Nurses (APRN) (NP/CNM/CNS/CRNA) and Physician Assistants (PAs) must complete 24 hours of specialized training to prescribe buprenorphine. The training includes 8 hours of waiver training and an additional 16 hours of training.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session.
Instructions on how to log on to Part 2 of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please allow up to 48 hours to receive the email. It is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions and case studies in order for the AOAAM to verify your attendance. PHONE ONLY PARTICIPATION DOES NOT QUALIFY FOR PARTICIPATION CREDIT.


CONTINUING MEDICAL EDUCATION: This session has been approved for 4.25 AOA Category 1-A CME credits, providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources visit: www.pcssnow.org.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Stephen A. Wyatt, DO

Medical Director, Addiction Medicine Carolinas HealthCare System Charlotte, NC

Dr. Wyatt is a graduate Chicago College of Osteopathic Medicine. He practiced Emergency Medicine in Michigan for 13 years before entering a psychiatric residency at University Hospitals of Cleveland, Case Western Reserve University in 1993.  He then entered a NIDA Clinical Research Fellowship in the Yale School of Medicine in Addiction Psychiatry. His primary interest and research has been in co-morbid problems, adolescents, and education.  He sits on a variety of Federal committees on substance use disorders including the Physician Clinical Support System, PCSS, for Medication Assisted Treatment.  He served on the expert panel for office based use of Buprenorphine for the Federation of State Medical Boards. He is the Past President of the Connecticut Society of Addiction Medicine and the American Osteopathic Academy of Addiction Medicine. He was a Board Co-chair for the Connecticut Department of Mental Health and Addiction Services   He has been active in all levels of medical education in advocating for greater understanding and improvement in treatment of substance use problems in the provision of care.

This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit.

CME certificates will be provided 30 days after the training date.

Key:

Complete
Failed
Available
Locked
Pre-Test
10 Questions  |  1 attempt  |  0/10 points to pass
10 Questions  |  1 attempt  |  0/10 points to pass In order to be CME compliant, a pre-test is required. You will not be graded on this quiz but will be required for CME eligibility. Once completed, regardless of score, you will be allowed to participate in the webinar.
PCSS Office-Based Treatment for Opioid Use Disorders Webinar - 12/27/2021
12/27/2021 at 8:00 PM (EST)   |  300 minutes
12/27/2021 at 8:00 PM (EST)   |  300 minutes This is PART 1 of the 8-hour waiver eligibility training. NOTE: This training has a starting time of 5:00 pm Pacific Time Zone. Please check your time zone for start time. Please download the Zoom app prior to training. https://zoom.us/ent?zcid=2582 Physicians are required to apply to the Drug Enforcement Agency for a waiver to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder. Those physicians who want to treat more than 30 patients at any one time, must take the 8-hour waiver course. To treat more than 30 patients, Advanced Practice Registered Nurses (APRN) (NP/CNM/CNS/CRNA) and Physician Assistants (PAs) must complete 24 hours of specialized training to prescribe buprenorphine. The training includes 8 hours of waiver training and an additional 16 hours of training. The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session. Instructions on how to log on to Part 2 of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please allow up to 48 hours to receive the email. It is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions and case studies in order for the AOAAM to verify your attendance. PHONE ONLY PARTICIPATION DOES NOT QUALIFY FOR PARTICIPATION CREDIT. Access to Part 2 will be emailed to you after successful participation of Part 1 is verified. Please note that this may take up to 48 hours. Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Certificate of Attendance
No credits available  |  Certificate available
No credits available  |  Certificate available This certificate certifies that you have successfully completed Part 1 of the training and have earned 4.25-hours of attendance credit to be applied towards the total required training of 8-hours. You are eligible to advance to Part 2 for the remaining 3.75-hours of training. A follow-up email will be sent to you within 48 hours of the training date with the link and directions on how to access Part 2. If you wish to receive CME credits for the training, please complete the remaining components of Part 1 which include a survey and post-webinar quiz.
OBOT Survey / 4.25-Hour
8 Questions
8 Questions As a CME accredited sponsor, it is required that an evaluation be provided to you in order to be compliant with CME regulations. Once you complete the survey, a certificate will be available for download/print.
Post-Test
10 Questions  |  3 attempts  |  7/10 points to pass
10 Questions  |  3 attempts  |  7/10 points to pass As an accredited sponsor and to meet CME compliance, a post-test is required for CME eligibility. You will need a minimum score of 70% in order to be eligible for CME.
Certificate of Attendance and CME
Up to 4.25 medical credits available  |  Certificate available
Up to 4.25 medical credits available  |  Certificate available The Certificate of Attendance and CME is your combined certificate verifying the training hours from Part 1, along with your CME credits earned. The Certificate of Attendance and CME verifies that the specified hours of training were completed and can be applied toward obtaining the waiver in the office-based treatment of opioid use disorders. Furthermore, please use this certificate to report CME to your respective accrediting board. If you are a D.O., the AOAAM will report your CME credits to the AOA for you. Please allow 90 days for the AOAAM to complete this process.